Regulatory News
Wednesday, April 6, 2016
REFILE-UPDATE 3-Pfizer, Allergan scrap $160 bln deal after U.S. tax rule change
April 6 (Reuters) - U.S. drugmaker Pfizer Inc and
Ireland-based Allergan Plc walked away from their $160
billion merger on Wednesday, a major win for President Barack
Obama, who has been pushing to...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment